153 related articles for article (PubMed ID: 6946246)
1. Prevention of tumors in rats by cross-protective immunization.
Fish DC; Bare AL; Djurickovic DB; Huebner RJ
J Natl Cancer Inst; 1981 Nov; 67(5):1041-51. PubMed ID: 6946246
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
[TBL] [Abstract][Full Text] [Related]
3. Prevention of transplantable tumors by adoptive transfer of spleen cells from immunized rats.
Fish DC; Djurickovic DB; Huebner RJ
J Immunol; 1979 Dec; 123(6):2658-63. PubMed ID: 501086
[TBL] [Abstract][Full Text] [Related]
4. Cell surface antigens in a rat colon cancer model: correlation with inhibition of tumor growth.
Steele G; Sjogren HO
Surgery; 1977 Jul; 82(1):164-9. PubMed ID: 877853
[TBL] [Abstract][Full Text] [Related]
5. Surface antigens of BK virus-induced tumor cells.
Karjalainen HE
Med Biol; 1981 Feb; 59(1):35-40. PubMed ID: 6267387
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of cross-reacting tumor rejection antigens in chemically induced respiratory tract carcinomas in rats.
Jamasbi RJ; Nettesheim P
Cancer Res; 1977 Nov; 37(11):4059-63. PubMed ID: 71203
[TBL] [Abstract][Full Text] [Related]
7. Increase in immunogenicity with concomitant loss of tumorigenicity of respiratory tract carcinomas during in vitro culture.
Jamasbi RJ; Nettesheim P
Cancer Res; 1979 Jul; 39(7 Pt 1):2466-70. PubMed ID: 87265
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. I. Protective cross-immunity between transplantable tumor lines.
Edelman AS; Xue B; Sanchez P; Thorbecke GJ
J Immunol; 1985 Sep; 135(3):2206-12. PubMed ID: 3926898
[TBL] [Abstract][Full Text] [Related]
9. Common tumor rejection antigens in methylcholanthrene-induced squamous cell carcinomas of mice detected by tumor protection and a radioisotopic footpad assay.
Economou GC; Takelchi N; Boone CW
Cancer Res; 1977 Jan; 37(1):37-41. PubMed ID: 63329
[TBL] [Abstract][Full Text] [Related]
10. Relationship between rejection of several syngeneic tumors and retrovirus production by 5-bromodeoxyuridine-grown melanoma cells: lack of protection in natural killer-deficient beige mice.
Silagi S; Calvelli TA
Cancer Res; 1982 Jul; 42(7):2562-6. PubMed ID: 7083149
[TBL] [Abstract][Full Text] [Related]
11. Role of host antigen receptor-bearing and antigen receptor-negative cells in immune response to rat adenocarcinoma 13762.
Frey AB
J Immunol; 1996 May; 156(10):3841-9. PubMed ID: 8621922
[TBL] [Abstract][Full Text] [Related]
12. Transplantation immunity and cross-protection of two cultured murine colon lines.
Sato N; Michaelides MC; Wallack MK
J Natl Cancer Inst; 1983 Feb; 70(2):261-5. PubMed ID: 6571935
[TBL] [Abstract][Full Text] [Related]
13. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
[TBL] [Abstract][Full Text] [Related]
14. Characterization of growth properties and demonstration of the tumor-specific transplantation antigens of Morris hepatomas.
Wepsic HT; Nickel R; Alaimo J
Cancer Res; 1976 Jan; 36(1):246-50. PubMed ID: 174809
[TBL] [Abstract][Full Text] [Related]
15. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
[No Abstract] [Full Text] [Related]
16. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
[TBL] [Abstract][Full Text] [Related]
17. Expression of activated H-rasval12 in nontumorigenic and non-cross-reactive syngeneic cells induces tumor antigens cross-reactive with rat mammary adenocarcinoma 13762.
Frey AB; Cestari S
J Immunol; 1995 Nov; 155(10):4783-9. PubMed ID: 7594480
[TBL] [Abstract][Full Text] [Related]
18. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
19. Growth suppression of subcutaneously inoculated hepatic tumors after injection of syngeneic liver cells into the subcutaneous tissue of rats.
Kamei H; Kondo T; Momoi T; Terabe K; Sugimoto K
J Natl Cancer Inst; 1976 Feb; 56(2):415-7. PubMed ID: 176387
[TBL] [Abstract][Full Text] [Related]
20. Protection of mice against syngeneic C1300 neuroblastoma challenge by immunization with membranes of C1300 neuroblastoma cells.
Lauro G; Businaro R; Butler RH; Revoltella R
J Natl Cancer Inst; 1980 May; 64(5):1169-72. PubMed ID: 6929017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
